InsiderTrades

Krishnamohan Neha

SEC CIK 1866171 · EDGAR

Buying vs selling by month open-market trades, last 24 months, all 2 companies
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ARQTArcutis Biotherapeutics, Inc.Dir 27.9K — $939.5K 62023-05-312026-06-05
ARTVArtiva Biotherapeutics, Inc.CFO 99.4K — — 42024-09-122025-11-15

Most active insiders at ARQT, 12 months

#InsiderTitleBoughtSold
1 Watanabe ToddSee Remarks, Dir —$5.32M
2 Welgus Howard G.Dir —$2.43M
3 Matsuda MasaruSee Remarks —$2.21M
4 Burnett PatrickSee Remarks —$2.02M
5 Leonard Keith RDir —$997.1K
6 Curran TerrieDir —$984.0K
7 Edwards Larry ToddSee Remarks —$968.4K
8 Krishnamohan NehaDir —$939.5K
9 LIN SUE-JEANDir —$898.5K
10 Gilbert Halley EDir —$455.5K

Transactions 10

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-09 21:20 2026-06-05 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir A - Grant $0.00 +5,778 27.9K +26% $0
2025-11-17 2025-11-15 ARTV Artiva Biotherapeutics, Inc. Krishnamohan Neha CFO F - Tax $3.25 -3,490 99.4K -3% -$11.3K
DM 2025-11-17 2025-11-13 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir S - Sale+OE $23.20 -40.5K 23.4K -63% -$939.5K
DM 2025-11-17 2025-11-13 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir M - OptEx $8.28 +39.3K 50.4K +353% +$325.2K
M 2025-08-18 2025-05-15+ ARTV Artiva Biotherapeutics, Inc. Krishnamohan Neha CFO F - Tax $2.63 -7,154 102.8K -7% -$18.8K
D 2025-06-16 2025-06-12 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir A - Grant $0.00 +7,609 23.4K +48% $0
2025-02-28 2025-02-26 ARTV Artiva Biotherapeutics, Inc. Krishnamohan Neha CFO A - Grant $0.00 +60.0K 110.0K +120% $0
2024-09-13 2024-09-12 ARTV Artiva Biotherapeutics, Inc. Krishnamohan Neha CFO A - Grant $0.00 +50.0K 50.0K New $0
D 2024-06-18 2024-06-14 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir A - Grant $0.00 +10.1K 15.7K +181% $0
D 2023-06-02 2023-05-31 ARQT Arcutis Biotherapeutics, Inc. Krishnamohan Neha Dir A - Grant $0.00 +4,375 5,607 +355% $0

Purchase Sale Sale after option exercise All abbreviations